FDA provided Emergency Use Authorization to PerkinElmer for COVID-19 testing
On Mar. 24, 2020, PerkinElmer announced the U.S. Food and Drug Administration (FDA) had provided Emergency Use Authorization…
Patients with severe Coronavirus disease could offer clues to treatment
On Mar. 24, 2020, a new international project aims to enroll 500 COVID-19 patients to search for genetic…
Oxford University’s COVID-19 research received government funding
On Mar. 24, 2020, three Oxford University-based COVID-19 projects were among the first to benefit from a share…
Biotechnology | COVID-19 | Diagnostics | FDA
bioMerieux received FDA Emergency Use Authorization for BIOFIRE COVID-19 test
On Mar. 24, 2020, bioMerieux announced that BioFire Diagnostics, its subsidiary specialized in syndromic infectious disease testing, had…
Dynavax and Clover Biopharmaceuticals announced COVID-19 research collaboration
On Mar. 24, 2020, Dynavax Technologies and Clover Biopharmaceuticals, a China-based global clinical-stage biotechnology company, announceda research collaboration…
Mesa Biotech received Emergency Use Authorization from FDA for 30 minute point ofcCare molecular COVID-19 test
On Mar. 24, 2020, Mesa Biotech announced it had received Emergency Use Authorization (EUA) from the FDA for…
BioSig subsidiary NeuroClear acquired license for a broad-spectrum anti-viral agent that may treat COVID-19
On Mar. 24, 2020, BioSig Technologies announced that its majority-owned subsidiary NeuroClear Technologies, acquired the rights to develop…
BioReference Laboratories and City of Miami provided testing for Coronavirus Disease 2019
On Mar. 24, 2020, BioReference Laboratories, an OPKO Health company, announced a collaboration with the City of Miami…
Emerald Organic and Todos Medicalfor JV to supply USwith COVID-19 rapid point-of-care testing kits
On Mar. 24, 2020, Emerald Organic Products and Todos Medical announced the creation of Corona Diagnostics, LLC, a…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | Vaccine
$1.6 million gift from Morris-Singer Foundation established COVID-19 hotline and telemedicine services for primary care
On Mar. 24, 2020, the Andrew and Corey Morris-Singer Foundation donated $1.6 million to OHSU to support the…
Windtree announced clinical study of lung injury treatment in COVID-19 patients with its KL4 surfactant therapy
On Mar. 24, 2020, Windtree Therapeutics announced it will study its proprietary KL4 surfactant to potentially mitigate the…
Resverlogix invited collaborations for use of Apabetalone in trials and studies to Combat spread of COVID-19
On Mar. 23, 2020, Resverlogix announced that it was seeking to collaborate with organizations currently testing therapies for…
COVID-19 | Diagnostics | Life Science News | NIH | Non-Profit Research | Therapeutics | U.S. Congress | Vaccine
NIH online resources support COVID-19 workers training to protect their own health
On Mar. 23, 2020, the National Institutes of Health (NIH) announced that it had launched an important online…
First patients enrolled in new Oxford University clinical trial of possible COVID-19 treatments
On Mar. 23, 2020, researchers from the University of Oxford the launch of a new clinical trial to…
UK launched whole genome sequence alliance to map spread of coronavirus
On Mar. 23, 2020, the UK Government announced funding of £20 million to support clinicians and scientists in…
Amgen Foundation committed up to $12.5 million to support COVID-19 relief efforts
On Mar. 23, 2020, the Amgen Foundation announced an initial commitment of up to $12.5 million to support…
Sorrento and SmartPharm Therapeutics announced research and development collaboration develop a next-generation, gene-encoded antibody vaccine for COVID-19
On Mar. 23, 2020, Sorrento and SmartPharm Therapeutics announced a research and development collaboration to develop a next-generation,…
Emory’s DRIVE, Ridgeback partnered for drug versus coronavirus
On Mar. 23, 2020, Drug Innovation Ventures at Emory (DRIVE), and Ridgeback Biotherapeutics announced a collaboration to rapidly…
COVID-19 pandemic drove accelerated demand for Covetrus online pharmacy services
On Mar. 23, 2020, Covetrus reported that the company saw strong demand in its prescription management and online…
serum therapy used as possible COVID-19 treatment
On Mar. 23, 2020, researchers at Washington University School of Medicine in St. Louis announced they were investigating…
Heat Biologics and University of Miami developed Proprietary COVID-19 diagnostic tests under collaborative research agreement
On Mar. 23, 2020, Heat Biologics announced that it was collaborating with the University of Miami to develop…
LabCorp developing options to prioritize COVID-19 testing for inpatient population
On Mar. 23, 2020, LabCorpï¾® announced that it is exploring all options to prioritize COVID-19 testing for the…
Novan to explore use Nitricil technology as potential topical oral or nasal treatment option for COVID-19
On Mar. 23, 2020, Novan announced that it intends to explore the use of its proprietary Nitricil technology…
BioReference Laboratories and City of Detroit provide testing for Coronavirus disease 2019
On Mar. 23, 2020, BioReference Labs, an OPKO Health company, announced a collaboration with the City of Detroit…
Soligenix and University of Hawaii at Manoa initiate work on novel Coronavirus vaccine for COVID-19
On Mar. 23, 2020, Soligenix announced that its ongoing collaboration with the University of Hawaii at Manoa (UH…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | Vaccine
CSL Group to help battle Coronavirus
On Mar. 23, 2020, CSL announced that it was exploring development of a hyperimmune serum that could be…
FDA Issues first Emergency Use Authorization for Point of Care Diagnostic
On Mar. 21, 2020, the FDA issued the first emergency use authorization for a point-of-care COVID-19 diagnostic for…
Quest Diagnostics dedicated special hours for non-COVID-19 testing for older and Highly vulnerable patients
On Mar. 21, 2020, through its “Peace of Mind” program, Quest Diagnostics took extra measures to ensure individuals…
NIH shifted non-mission-critical laboratory operations to minimal maintenance phase
On Mar. 20, 2020, to further reduce the risk of transmission of COVID-19 and enhance the safety of…
Novartis commited to donate up to 130 million doses of hydroxychloroquine to support the global COVID-19 pandemic response
On Mar. 20, 2020, Novartis announced its commitment to donate up to 130 million doses of generic hydroxychloroquine…